Congress trades

Balchem Corp (BCPC)

Specialty Chemicals, listed on NASDAQ.

29 Congress tradeslast filed Oct 12, 2026

Share
Download on the App StoreGet it on Google Play

Free on iOS and Android

Scan to get
the app

EarningsQ3 FY2026 · reported Oct 23, 2026

Balchem beat by 9.8% on adjusted EPS.

$1.57 a share against a $1.43 consensus. Revenue $291M against $289M, in line.

EPS

Reported$1.57
Consensus$1.43

Revenue

Reported$291M
Consensus$289M

Beat 4In line 1Miss 1

EPS against the consensus, quarter by quarter. Outlined: a GAAP figure against an adjusted consensus.

Next report Feb 19, 2027. Consensus $1.41 a share.

Every quarter

Money managers13F filings for Jun 30, 2026

416

institutions reported Balchem shares in 13F filings for Jun 30, 2026. BlackRock, Inc. held the largest stake, $838.7M.

The largest holders

BlackRock, Inc.$838.7M
Vanguard Portfolio Management LLC$375.3M
Vanguard Capital Management LLC$244.2M
Every holder

CongressSTOCK Act disclosures to the House and Senate

20 Congress disclosures shown, from 3 members.

30dMedian delayof the 45 day limit
11 buys · 9 sellsPurchases and sales in the disclosures shown

2 members of Congress report a position in BCPC, by our estimate. Who holds it

Every Congress trade in BCPCEvery disclosure
Companyfrom the company's filings and listing, as of Nov 10, 2026

About Balchem Corp

Exchange
NASDAQ
Sector
Basic Materials
Industry
Chemicals - Specialty
Chief executive
Theodore L. Harris
Employees
1,430
Listed since
Jun 3, 1986
Market value
$5.6B
Price to earnings (12 mo)
32.8
Net income per share, as reported (12 mo)
$5.33
Dividend yield
0.55%

www.balchem.com

Earnings6 reported quarters · next on Feb 19, 2027

Earnings

QuarterEPSEPS expectedRevenueRevenue expectedResult
Q3 FY2026reported Oct 23, 2026$1.57$1.43$290.7M$289.2MEPS beatRevenue in line
Q2 FY2026reported Jul 31, 2026$1.40$1.27$284.0M$268.5MEPS beat, GAAPRevenue beat
Q1 FY2026reported Apr 30, 2026$1.25$1.33$270.7M$266.5MEPS miss, GAAPRevenue beat
Q4 FY2025reported Feb 20, 2026$1.31$1.29$263.6M$259.6MEPS beatRevenue beat
Q3 FY2025reported Oct 21, 2025$1.35$1.36$267.6M$259.6MEPS in lineRevenue beat
Q2 FY2025reported Jul 31, 2025$1.27$1.25$255.5M$257.6MEPS beatRevenue in line

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.

No earnings call briefs on BCPC yet. Briefs from every company we cover.

Analysts

Analyst ratings and price targets

Past year Each firm's latest target, newest first

Each firm's latest price target on BCPC, newest first
FirmRatingTargetActionDate
H.C. WainwrightBuy$210Cut from $215
Rothschild & Co RedburnNeutral$162Initiated

Each firm's latest target from the past year, with the rating stated with its note or within three days of it. These are the firms' own views, not GetSignal's, and we do not endorse them. Not investment advice.

Ratings and targets come from licensed market data providers. A target is listed only after its firm and company are confirmed against a report of the note. As of Nov 11, 2026.

Proxy statementas filed for fiscal 2025 · proxy filed Apr 27, 2026

Executive pay

Ted Harris’s pay as CEO came to $7.9M for fiscal 2025.
ExecutiveSalaryStock awardsOtherTotal
Ted HarrisChairman, President and Chief Executive Officer$1.2M$3.2M$3.5M$7.9M
C. Martin BengtssonExecutive Vice President and Chief Financial Officer$614K$1.1M$1.2M$3.0M
Hatsuki MiyataExecutive Vice President, Chief Legal Officer and Secretary$526K$878K$988K$2.4M
Frederic BonedSenior Vice President and General Manager, Human Nutrition and Health$542K$753K$957K$2.3M
M. Brent TignorSenior Vice President and Chief Human Resources Officer$447K$615K$719K$1.8M

The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing

13F filings13F positions as of Jun 30, 2026

Institutional holders

HolderValueSharesShares vs prior qtr% of shares out
BlackRock, Inc.$838.7M4,964,479+2.5%15.40%
Vanguard Portfolio Management LLC$375.3M2,221,267+1.3%6.89%
Vanguard Capital Management LLC$244.2M1,445,369+0.9%4.48%
State Street Corp$216.5M1,281,552+3.3%3.97%
Geode Capital Management, LLC$189.6M1,122,146+7.2%3.48%
Conestoga Capital Advisors, LLC$183.8M1,087,871-13.1%3.37%
Wasatch Advisors LP$177.5M1,050,780-26.2%3.26%
Morgan Stanley$141.0M834,445-2.7%2.59%
Geneva Capital Management LLC$115.4M683,102-19.3%2.12%
First Trust Advisors LP$104.3M617,233+36.2%1.91%
Dimensional Fund Advisors LP$103.1M610,047+2.2%1.89%
FMR LLC$94.7M560,255-6.4%1.74%

A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.

STOCK Act20 disclosures of 29 on record · median 30d of the 45 allowed

Congress trades in BCPC

Since the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.

MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+4.7% since the tradeEstimated entry price $165.76, close on Thu Sep 17Current price $173.54, close on Tue Nov 10Sep 17, 2026Oct 12, 202625d
Gilbert Ray Cisneros, Jr.Filed lateStockPurchase$1,001 - $15,000+7.0% since the tradeEstimated entry price $162.15, close on Fri Jul 10Current price $173.54, close on Tue Nov 10Jul 10, 2026Sep 4, 202656d
Josh GottheimerJointStockSale$1,001 - $15,000+8.7% since the saleEstimated exit price $159.64, close on Wed Apr 9, 2025Current price $173.54, close on Tue Nov 10Apr 9, 2025May 14, 202535d
Josh GottheimerJointStockSale$1,001 - $15,000+8.3% since the saleEstimated exit price $160.28, close on Thu Dec 2, 2021Current price $173.54, close on Tue Nov 10Dec 2, 2021Jan 10, 202239d
Gilbert Ray Cisneros, Jr.StockPurchase$1,001 - $15,000+85.7% since the tradeEstimated entry price $93.43, close on Thu May 21, 2020Current price $173.54, close on Tue Nov 10May 21, 2020Jun 16, 202026d
Ro KhannaStockSale$1,001 - $15,000n/aApr 7, 2020May 13, 202036d
Ro KhannaStockPurchase$1,001 - $15,000n/aOct 15, 2019Nov 12, 201928d
Ro KhannaStockPurchase$1,001 - $15,000n/aOct 21, 2019Nov 12, 201922d
Ro KhannaStockSale$1,001 - $15,000n/aSep 11, 2019Oct 16, 201935d
Ro KhannaStockPurchase$1,001 - $15,000n/aAug 2, 2019Sep 11, 201940d
Ro KhannaStockSale$1,001 - $15,000n/aAug 12, 2019Sep 11, 201930d
Ro KhannaStockPurchase$1,001 - $15,000n/aJun 3, 2019Jul 11, 201938d
Ro KhannaStockSale$1,001 - $15,000n/aApr 29, 2019May 10, 201911d
Ro KhannaStockPurchase$1,001 - $15,000n/aFeb 20, 2019Mar 8, 201916d
Ro KhannaStockSale$1,001 - $15,000n/aJan 14, 2019Feb 12, 201929d
Ro KhannaStockSale$1,001 - $15,000n/aJan 18, 2019Feb 12, 201925d
Ro KhannaStockPurchase$1,001 - $15,000n/aOct 25, 2018Nov 9, 201815d
Ro KhannaStockPurchase$1,001 - $15,000n/aMay 8, 2018Jun 8, 201831d
Ro KhannaStockSale$1,001 - $15,000n/aApr 3, 2018May 10, 201837d
Ro KhannaStockPurchase$1,001 - $15,000n/aMay 4, 2018May 10, 20186d

Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it.

A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.

Every Congress trade in BCPC filterable by party, chamber, type and account.

STOCK Act2 members · estimate, as of Nov 10, 2026

Members of Congress reporting a position

2 members report a position (estimated).
MemberParty, chamberEstimated positionShare of their portfolio
Gilbert Ray Cisneros, Jr.Democrat · House$50,001 - $100,0000.2%
Josh GottheimerDemocrat · House$1,001 - $15,000<0.1%

The largest estimated position is in the $50,001 - $100,000 band. Estimate, as of Nov 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, marked to the latest close we hold. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

A STOCK Act disclosure gives each trade as a band of dollar values, which we do not narrow, and is due within 45 days of the trade. An option is described by its underlying company's name; its row says it is an option.

Data as of Nov 11, 2026.

Methodology · Guide to Form 4 · Guide to the STOCK Act

Questions

What the filings on BCPC show and how current they are.

Which members of Congress have traded BCPC?

Gilbert Ray Cisneros, Jr., Josh Gottheimer and Ro Khanna disclosed BCPC transactions in the filings shown here.

Which members of Congress hold BCPC?

2 members of Congress report a position in BCPC in the estimate we hold as of Nov 10, 2026. The estimated positions belong to Gilbert Ray Cisneros, Jr. and Josh Gottheimer. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

How quickly are BCPC trades disclosed?

Congressional disclosures took a median of 30 days, against the 45 the STOCK Act allows.

Related companies

traded by the same members

See every company we track